Pseudouridine

03/01/2015 - "Interestingly, recent reports indicate that the levels of subsets of H/ACA snoRNAs required for pseudouridine modifications at specific sites on rRNA are altered in several diseases, particularly cancer. "
02/01/1999 - "The sensitivity of established assay system was sufficient for quantitative determination of serum pseudouridine levels in healthy individuals and cancer patients. "
03/01/1995 - "Besides, pseudouridine levels could elevate before positive localization and reduce to normal levels after tumor resection. "
01/01/1994 - "These findings indicate that urinary pseudouridine may be a useful tumor marker in patients with SCLC."
01/01/1994 - "Although urinary pseudouridine is not a specific marker for SCLC, it represents the tumor burden and reflects the clinical status. "

11/01/1996 - "In 54 cases of cirrhotic ascites and 17 cases of HC ascites, all histologically diagnosed, ascitic pseudouridine concentrations discriminated cirrhotic from HC ascites. "
11/01/1996 - "Ascitic pseudouridine discriminates between hepatocarcinoma-derived ascites and cirrhotic ascites."
08/01/1972 - "The thiolation, methylation, and formation of pseudouridine and dihydrouridine in tRNA of regenerating rat liver, human phytohemagglutinin stimulated lymphocytes, and Novikoff ascites cells."
07/01/1995 - "Along with the growth of ascites tumor, the amounts of 1-methyladenosine and pseudouridine in the serum increased. "
07/01/1995 - "To examine the efficacy of the modified nucleosides in the serum as tumor markers, ascites and solid tumor mouse models were prepared, and the amounts of 1-methyladenosine and pseudouridine in the serum were determined. "

08/01/1983 - "Patients with childhood ALL at initial diagnosis or in relapse had significantly higher concentrations of 1-methylinosine, N2,N2-dimethylguanosine, 1-methylguanosine, and pseudouridine in their urine when compared to the concentrations in either patients in remission (P less than 0.001, P less than 0.001, P less than 0.01, and P less than 0.05, respectively) or normal controls (P less than 0.001, P less than 0.02, P less than 0.01, and P less than 0.001, respectively). "

01/01/1995 - "Almost half of them suffered from IR though they did not differ from insulin-sensitive patients in age, sex, prevalence of various kidney diseases, hypertension, clearance of endogenous creatinine, serum creatinine, urea, uric acid, hippurate or pseudouridine concentrations. "

01/01/1995 - "Almost half of them suffered from IR though they did not differ from insulin-sensitive patients in age, sex, prevalence of various kidney diseases, hypertension, clearance of endogenous creatinine, serum creatinine, urea, uric acid, hippurate or pseudouridine concentrations. "